Natriuretic peptide regulation of endochondral ossification - Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway

被引:166
作者
Yasoda, A
Ogawa, Y
Suda, M
Tamura, N
Mori, K
Sakuma, Y
Chusho, H
Shiota, K
Tanaka, K
Nakao, K
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 606, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Kyoto 606, Japan
关键词
D O I
10.1074/jbc.273.19.11695
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The natriuretic peptide family consists of three structurally related endogenous ligands: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), The biological actions of natriuretic peptides are thought to be mediated through the activation of two guanylyl cyclase (GC)-coupled receptor subtypes (GC-A and GC-B), In this study, we examined the effects of ANP and CNP, which are endogenous ligands for GC-A and GC-B, respectively, on bone growth using an organ culture of fetal mouse tibias, an in vitro model of endochondral ossification. CNP increased the cGMP production much more potently than ANP, thereby resulting in an increase in the total longitudinal bone length. Histological examination revealed an increase in the height of the proliferative and hypertrophic chondrocyte zones in fetal mouse tibias treated with CNP, The natriuretic peptide stimulation of bone growth, which was mimicked by 8-bromo-cGMP, was inhibited by HS-142-1, a non-peptide GC-coupled natriuretic peptide receptor antagonist. The spontaneous increase in the total longitudinal bone growth and cGMP production was also inhibited significantly by HS-142-1. CNP mRNA was expressed abundantly in fetal mouse tibias, where no significant amounts of ANP and BNP mRNAs were detected. A considerable amount of GC-B mRNA was present in fetal mouse tibias, This study suggests the physiologic significance of the CNP/GC-B pathway in the process of endochondral ossification.
引用
收藏
页码:11695 / 11700
页数:6
相关论文
共 42 条
[1]   PARATHYROID HORMONE-RELATED PEPTIDE-DEPLETED MICE SHOW ABNORMAL EPIPHYSEAL CARTILAGE DEVELOPMENT ALTERED ENDOCHONDRAL BONE-FORMATION [J].
AMIZUKA, N ;
WARSHAWSKY, H ;
HENDERSON, JE ;
GOLTZMAN, D ;
KARAPLIS, AC .
JOURNAL OF CELL BIOLOGY, 1994, 126 (06) :1611-1623
[2]  
[Anonymous], HYPERTENSION PATHOPH
[3]   CHONDROCYTE DIFFERENTIATION [J].
CANCEDDA, R ;
CANCEDDA, FD ;
CASTAGNOLA, P .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 159, 1995, 159 :265-358
[4]  
CHINKERS M, 1991, ANNU REV BIOCHEM, V60, P553, DOI 10.1146/annurev.biochem.60.1.553
[5]  
CHRISMAN TD, 1993, J BIOL CHEM, V268, P3698
[6]   Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].
Colvin, JS ;
Bohne, BA ;
Harding, GW ;
McEwen, DG ;
Ornitz, DM .
NATURE GENETICS, 1996, 12 (04) :390-397
[7]   DIFFERENTIAL EXPRESSION OF NATRIURETIC PEPTIDE GENES IN CARDIAC AND EXTRACARDIAC TISSUES [J].
DAGNINO, L ;
DROUIN, J ;
NEMER, M .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (09) :1292-1300
[8]   Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].
Deng, CX ;
WynshawBoris, A ;
Zhou, F ;
Kuo, A ;
Leder, P .
CELL, 1996, 84 (06) :911-921
[9]  
HAGIWARA H, 1994, J BIOL CHEM, V269, P10729
[10]   cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells [J].
Hagiwara, H ;
Inoue, A ;
Yamaguchi, A ;
Yokose, S ;
Furuya, M ;
Tanaka, S ;
Hirose, S .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (05) :C1311-C1318